Combinature
Trademark details
Combinature® is a registered trademark used for Chemical Products For Industrial, Scientific and Medical Use In the Fields of Molecular Biology, Pharmacology, Medicine, and Oncology and owned by Combinature Biopharm AG.. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Chemical Products For Industrial, Scientific and Medical Use In the Fields of Molecular Biology, Pharmacology, Medicine, and Oncology Agents For Research Use Pharmaceutical Preparations For the Treatment of Arteriosclerosis, Hypertension, Schizophrenia, Morbus Alzheimer, Morbus Parkinson, Bacterial or Viral Infectious Diseases, Cancer Veterinary Pharmaceutical Preparations For Clinical, Medical and Scientific Use Diagnostics Reagents For Clinical and Medical Laboratory Use Sanitary Preparations Vitamins Disinfectants For Commercial, Industrial and Domestic Use Fungicides For Commercial, Industrial and Domestic Use Herbicides For Commercial, Industrial and Domestic Use Food For Babies Preparations For Destroying Vermin For Commercial, Industrial and Domestic Use Medical Plasters Chemical, Biochemical, Analytical Laboratory Research In the Fields of Molecular Biology, Pharmacology and Medicine Research and Development of New Products For Other In the Fields of Molecular Biology, Pharmacology and Medicine |
| Serial Number: | 76245511 |
| Registration Number: | 2665586 |
| Filing Date: | Apr 24, 2001 |
|
Last Applicant(s)/ Owner(s) of Record | Combinature Biopharm AG.Robert-Rossle-Str. 10 |
| Related Products: | Chemicals, Pharmaceuticals, Miscellaneous Services; Scientific and technological services, and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services |
News and Blogs
Total : 1 View more »
Schering inks deal-22/12/2003-ECN
...signed a research agreement to apply Combinature's proprietary combinatorial biosynthesis... Under the terms of agreement, Combinature will receive R&D payments and milestone...Schering Research Center Europe. 'Combinature's approach to combine natural product...
